EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.541
https://www.valueinhealthjournal.com/article/S1098-3015(23)00641-1/fulltext
Title :
EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00641-1&doi=10.1016/j.jval.2023.03.541
First page :
Section Title :
Open access? :
No
Section Order :
10024